Screener
Ionis Pharmaceuticals IONS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Proceeds from sale of short-term investments | 1,114,805 | 880,545 |
| Purchases of property, plant and equipment | (37,843) | (24,882) |
| Acquisition of licenses and other assets, net | (3,640) | (2,615) |
| Net cash provided by investing activities | 560,317 | 50,391 |
| Financing activities: | ||
| Proceeds from issuance of common stock through equity plans, net | 77,560 | 3,528 |
| Repayment of 0 percent convertible senior notes due 2026 | (432,511) | - |
| Principal payments on mortgage debt | (85) | (82) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's investing cash flow?
- Ionis Pharmaceuticals (IONS) reported investing cash flow of $23.5M in Q2 2026.
- How has Ionis Pharmaceuticals's investing cash flow changed year-over-year?
- Ionis Pharmaceuticals's investing cash flow increased by 119.6% year-over-year, from -$120.07M to $23.5M.
- What is the long-term trend for Ionis Pharmaceuticals's investing cash flow?
- Over 2 years (2021 to 2025), Ionis Pharmaceuticals's investing cash flow has grown at a 19.4% compound annual growth rate (CAGR), from $194.91M to -$277.78M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Ionis Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude